Erlotinib HCL for glioblastoma multiforme in first relapse, a phase II trial.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Yung, A; Vredenburgh, J; Cloughesy, T; Klencke, BJ; Mischel, PS; Bigner, DD; Aldape, K; Vanderburg, S; Prados, M

Published Date

  • July 15, 2004

Published In

Volume / Issue

  • 22 / 14

Start / End Page

  • 120S - 120S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 40th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • New Orleans, LA

Conference Start Date

  • June 5, 2004

Conference End Date

  • June 8, 2004